BioCina

Thebarton, Australia Founded: 2018 • Age: 8 yrs
CDMO offering microbial expression systems-based biologics development and manufacturing services
Request Access

About BioCina

BioCina is a company based in Thebarton (Australia) founded in 2018 by Ian Wisenberg.. BioCina offers products and services including Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development. BioCina operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.

  • Headquarter Thebarton, Australia
  • Founders Ian Wisenberg
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $3.3 M (USD), Grant

    Apr 26, 2023

  • Investors
    NHMRC

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BioCina

BioCina offers a comprehensive portfolio of products and services, including Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Service for bacterial protein expression and vaccine manufacturing.

Process for plasmid DNA adjuvants used in vaccines and therapies.

Production of messenger RNA for clinical and commercial applications.

Service to scale and optimize product processes for manufacturing.

Development of methods for testing and validating biologics programs.

People of BioCina
Headcount 50-200
Employee Profiles 27
Employee Profiles
People
Alex Pomerantz
Sr. Director Business Development
People
Jason Arcediano
Chief Commercial Officer
People
Samantha Kimber
Quality Operations Manager
People
Charles Vincent
Information Technology And CSV Manager

Unlock access to complete

Funding Insights of BioCina

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $3.3M
  • First Round

    (05 Apr 2022)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Grant - BioCina Valuation

investors

Apr, 2022 Amount Grant - BioCina Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioCina

BioCina has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NHMRC and Department of Industry, Science and Resources. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Funds medical research, advises government, and facilitates health professional networking in Australia.
Founded Year Domain Location
Government department focused on industry, science, and resource development in Australia.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioCina

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioCina

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biocina Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioCina

BioCina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Silicones, polymers, and bio-solutions are manufactured for various industries.
domain founded_year HQ Location
Gut microbiome insights, analytics, tests, and therapeutics are provided.
domain founded_year HQ Location
Microbial strains are manufactured by Enduro as a CDMO.
domain founded_year HQ Location
CDMO offers microbial expression systems-based biologics development
domain founded_year HQ Location
Offers microbial expression systems-based biologics development and manufacturing services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biocina

Frequently Asked Questions about BioCina

When was BioCina founded?

BioCina was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is BioCina located?

BioCina is headquartered in Thebarton, Australia. It is registered at Thebarton, South Australia, Australia.

Who is the current CEO of BioCina?

Ian Wisenberg is the current CEO of BioCina. They have also founded this company.

What does BioCina do?

BioCina was established in 2018 in Thebarton, Australia, as a contract development and manufacturing organization in the biotechnology sector. Microbial expression systems are employed for biologics development and production services. Operations focus on supporting clients through scalable manufacturing processes tailored to microbial platforms. The company serves global partners in the biopharmaceutical industry from its Australian base.

Who are the top competitors of BioCina?

BioCina's top competitors include Wacker Chemie, AMILI and Enduro.

What products or services does BioCina offer?

BioCina offers Microbial Manufacturing, pDNA Manufacturing, mRNA Manufacturing, Technology Transfer, and Analytical Development.

Who are BioCina's investors?

BioCina has 2 investors. Key investors include NHMRC, and Department of Industry, Science and Resources.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available